Cargando…

Pre-Analytical and Analytical Variables of Label-Independent Enrichment and Automated Detection of Circulating Tumor Cells in Cancer Patients

Circulating tumor cells (CTCs) are promising tools for risk prediction and the monitoring of response to therapy in cancer patients. Within the EU/IMI CANCER-ID consortium, we validated CTC enrichment systems for future inclusion into clinical trials. Due to the known heterogeneity of markers expres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koch, Claudia, Joosse, Simon A., Schneegans, Svenja, Wilken, Okka J. W., Janning, Melanie, Loreth, Desiree, Müller, Volkmar, Prieske, Katharina, Banys-Paluchowski, Malgorzata, Horst, Ludwig J., Loges, Sonja, Peine, Sven, Wikman, Harriet, Gorges, Tobias M., Pantel, Klaus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7072175/ https://www.ncbi.nlm.nih.gov/pubmed/32069934 http://dx.doi.org/10.3390/cancers12020442

Ejemplares similares

CD74 and CD44 Expression on CTCs in Cancer Patients with Brain Metastasis
por: Loreth, Desiree, et al.
Publicado: (2021)

Detection of Circulating Tumor Cells in Non-Small Cell Lung Cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2015)

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer
por: Elazezy, Maha, et al.
Publicado: (2021)

Discovery of Targetable Genetic Alterations in NSCLC Patients with Different Metastatic Patterns Using a MassARRAY-Based Circulating Tumor DNA Assay
por: Belloum, Yassine, et al.
Publicado: (2020)

Determination of PD-L1 Expression in Circulating Tumor Cells of NSCLC Patients and Correlation with Response to PD-1/PD-L1 Inhibitors
por: Janning, Melanie, et al.
Publicado: (2019)

Emerging Insights into Keratin 16 Expression during Metastatic Progression of Breast Cancer
por: Elazezy, Maha, et al.
Publicado: (2021)

Multicenter Evaluation of Independent High-Throughput and RT-qPCR Technologies for the Development of Analytical Workflows for Circulating miRNA Analysis
por: Babayan, Anna, et al.
Publicado: (2020)

EGFR and HER3 expression in circulating tumor cells and tumor tissue from non-small cell lung cancer patients
por: Scharpenseel, Heather, et al.
Publicado: (2019)

A novel microfluidic platform for size and deformability based separation and the subsequent molecular characterization of viable circulating tumor cells
por: Hvichia, G.E., et al.
Publicado: (2016)

Pre‐analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients
por: Schneegans, Svenja, et al.
Publicado: (2020)

Decellularized In Vitro Capillaries for Studies of Metastatic Tendency and Selection of Treatment
por: Huttala, Outi, et al.
Publicado: (2022)

Frequency of Circulating Tumor Cells (CTC) in Patients with Brain Metastases: Implications as a Risk Assessment Marker in Oligo-Metastatic Disease
por: Hanssen, Annkathrin, et al.
Publicado: (2018)

Biology, detection, and clinical implications of circulating tumor cells
por: Joosse, Simon A, et al.
Publicado: (2015)

Detection and Characterization of Estrogen Receptor α Expression of Circulating Tumor Cells as a Prognostic Marker
por: Ningsi, Retno, et al.
Publicado: (2022)

Breast cancer brain metastases: biology and new clinical perspectives
por: Witzel, Isabell, et al.
Publicado: (2016)

Combined Liquid Biopsy Methylation Analysis of CADM1 and MAL in Cervical Cancer Patients
por: Leffers, Markus, et al.
Publicado: (2022)

Characterization of different CTC subpopulations in non-small cell lung cancer
por: Hanssen, Annkathrin, et al.
Publicado: (2016)

Liquid biopsy in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2019)

Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells
por: Babayan, Anna, et al.
Publicado: (2016)

Targeting the EGF receptor family in non-small cell lung cancer—increased complexity and future perspectives
por: Boch, Tobias, et al.
Publicado: (2022)

Twinkle artifact in sonographic breast clip visualization
por: Maggie, Banys-Paluchowski, et al.
Publicado: (2022)

Increased serum levels of circulating exosomal microRNA-373 in receptor-negative breast cancer patients
por: Eichelser, Corinna, et al.
Publicado: (2014)

Detection and Monitoring of Tumor-Derived Mutations in Circulating Tumor DNA Using the UltraSEEK Lung Panel on the MassARRAY System in Metastatic Non-Small Cell Lung Cancer Patients
por: van der Leest, Paul, et al.
Publicado: (2023)

Male papillary breast cancer treated by wide resection and latissimus dorsi flap reconstruction: A case report and review of the literature
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2016)

ALCAM contributes to brain metastasis formation in non-small-cell lung cancer through interaction with the vascular endothelium
por: Münsterberg, Justine, et al.
Publicado: (2020)

Does Respect Foster Tolerance? (Re)analyzing and Synthesizing Data From a Large Research Project Using Meta-Analytic Techniques
por: Zitzmann, Steffen, et al.
Publicado: (2021)

Evaluation of serum epidermal growth factor receptor (EGFR) in correlation to circulating tumor cells in patients with metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2017)

Clinical relevance of blood-based ctDNA analysis: mutation detection and beyond
por: Keller, Laura, et al.
Publicado: (2020)

Clinical applications and utility of cell-free DNA-based liquid biopsy analyses in cervical cancer and its precursor lesions
por: Herbst, Johanna, et al.
Publicado: (2022)

Analytic cycles on real analytic manifolds
por: Bochnak, J, et al.
Publicado: (2002)

Evaluation of PD-L1 expression on circulating tumor cells (CTCs) in patients with advanced urothelial carcinoma (UC)
por: Bergmann, Sonja, et al.
Publicado: (2020)

Heterogeneity of Estrogen Receptor Expression in Circulating Tumor Cells from Metastatic Breast Cancer Patients
por: Babayan, Anna, et al.
Publicado: (2013)

Potential Role of Circulating Tumor Cell Detection and Monitoring in Breast Cancer: A Review of Current Evidence
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2016)

Liquid Biopsy in Breast Cancer
por: Banys-Paluchowski, Maggie, et al.
Publicado: (2020)

Influence of Androgens on Immunity to Self and Foreign: Effects on Immunity and Cancer
por: Ben-Batalla, Isabel, et al.
Publicado: (2020)

Advanced analytics methodologies : driving business with analytics
por: Chambers, Michele, et al.
Publicado: (2015)

Circulating Tumour Cell Release after Cement Augmentation of Vertebral Metastases
por: Mohme, Malte, et al.
Publicado: (2017)

Improved Detection of Circulating Tumor Cells in Metastatic Colorectal Cancer by the Combination of the CellSearch(®) System and the AdnaTest(®)
por: Gorges, Tobias M., et al.
Publicado: (2016)

Detection of Androgen Receptor Variant 7 (ARV7) mRNA Levels in EpCAM-Enriched CTC Fractions for Monitoring Response to Androgen Targeting Therapies in Prostate Cancer
por: Hille, Claudia, et al.
Publicado: (2019)

Elevated serum RAS p21 is an independent prognostic factor in metastatic breast cancer
por: Banys-Paluchowski, Malgorzata, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_c67prjm4et5lonc7dmro1vptc4